The Evolution of Treatments for Emmetropic Presbyopia - Scorecard - MDSpire
Advertisement
The Evolution of Treatments for Emmetropic Presbyopia
Often, these patients are unhappy with this reality check of aging and do not want to wear reading glasses, which is why practitioners and industry are always looking for ways to help. The challenge is to develop therapies that correct presbyopia while maintaining the emmetrope’s clear distance vision.
Clinical Scorecard: The Evolution of Treatments for Emmetropic Presbyopia
At a Glance
Category
Detail
Condition
Key Mechanisms
Ciliary muscle function and Bruch’s membrane choroid complex (BMCC) elasticity decline with age, affecting dynamic range of focus and lens flexibility.
Target Population
Care Setting
Key Highlights
Emmetropic presbyopes require vision correction for the first time after age 40.
Reading glasses and contact lenses are common but may not be well-tolerated.
Pupil-constricting eyedrops like pilocarpine offer a pharmaceutical option for near vision, but may cause side effects such as headaches and dim vision.
New therapies are in development to improve near vision without compromising distance vision.
Patients often prefer to avoid glasses, leading to a demand for innovative treatments.
Guideline-Based Recommendations
Diagnosis
Evaluate visual acuity and near vision difficulties in patients over 40.
Management
Consider reading glasses, progressive lenses, or contact lenses based on patient preference and educate patients on potential side effects.
Monitoring & Follow-up
Assess for side effects of treatments, particularly with pupil-constricting drops, and ensure patients understand these risks.
Risks
Evaluate patients for retinal complications before prescribing pupil-constricting eyedrops.
Patient & Prescribing Data
Pupil-constricting drops can improve near vision but may cause side effects like headaches and dim vision; monitor patient tolerance.
Clinical Best Practices
Discuss the pros and cons of each treatment option with patients.
Monitor for side effects and adjust treatment as necessary.
Stay updated on emerging therapies and their clinical implications.
Encourage follow-up visits to reassess treatment efficacy and side effects.
Our April issue arrives ahead of the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting and reflects the dynamic and ever-evolving landscape of refractive and cataract surgery.
